AstraZeneca loses Losec patents appeal
AstraZeneca's patents on its best-selling ulcer drug Losec were thrown out by the UK court of appeal just 10 days after a US court declared them valid. The Court of Appeal refused the Anglo-Swedish
AstraZeneca's patents on its best-selling ulcer drug Losec were thrown out by the UK court of appeal just 10 days after a US court declared them valid. The Court of Appeal refused the Anglo-Swedish